Journals / Eurasian Journal of Medicine / 2019 / Cilt: 51 - Sayı: 1

Effects of Conivaptan versus Mannitol on Post-Ischemic Brain Injury and Edema

Pages
42–48
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conivaptan treatment showed positive effects on serum biochemistry and tissue histology.Conclusion: Our findings revealed that conivaptan shows more diuretic activity than mannitol and triggers neither any damages nor edema in the brain tissue.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The aim of this study was to compare the effects of conivaptan, an arginine vasopressin antagonist, and mannitol, a sugar alcohol, on cerebral ischemia-induced brain injury and edema in rats.Materials and Methods: Fifty-eight 8-week-old male Sprague Dawley rats were randomly divided into five groups: control, ischemia–reperfusion (I/R)+saline, I/R+mannitol, I/R+10 mg/ml conivaptan, and I/R+20 mg/ml conivaptan.
📊
Key Findings & Data:Cerebral ischemia was induced by common carotid artery occlusion for 30 minutes.
💡
Conclusion & Impact:Conivaptan treatment showed positive effects on serum biochemistry and tissue histology.Conclusion: Our findings revealed that conivaptan shows more diuretic activity than mannitol and triggers neither any damages nor edema in the brain tissue.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: The aim of this study was to compare the effects of conivaptan, an arginine vasopressin antagonist, and mannitol, a sugar alcohol, on cerebral ischemia-induced brain injury and edema in rats.Materials and Methods: Fifty-eight 8-week-old male Sprague Dawley rats were randomly divided into five groups: control, ischemia–reperfusion (I/R)+saline, I/R+mannitol, I/R+10 mg/ml conivaptan, and I/R+20 mg/ml conivaptan. Cerebral ischemia was induced by common carotid artery occlusion for 30 minutes. Saline, mannitol, or conivaptan were administered intravenously at the onset of reperfusion. Blood and brain tissue samples were taken at the 6th hour of reperfusion. The electrolytes (Na+–K+–Cl−), osmolality, arginine vasopressin, albumin, progranulin (PGRN), neuron-specific enolase (NSE), and myeloperoxidase activity were measured in rat serum samples. Brain frontal/hippocampal sections were stained with hematoxylin–eosin and TUNEL techniques to evaluate histopathological changes.Results: Statistical analyses revealed that conivaptan caused significant changes in the electrolyte, NSE, and PGRN levels and osmolality when compared with mannitol. Conivaptan treatment showed positive effects on serum biochemistry and tissue histology.Conclusion: Our findings revealed that conivaptan shows more diuretic activity than mannitol and triggers neither any damages nor edema in the brain tissue. This study may provide beneficial information for the development of treatment strategies for ischemia-related cerebrovascular diseases.

🔖

Cite This Article

ÖZ, S., ŞAHİNTÜRK, V., MUSMUL, A., CAN, B., ALATAŞ, İ. Ö. (2022). Effects of Conivaptan versus Mannitol on Post-Ischemic Brain Injury and Edema. Eurasian Journal of Medicine, Cilt: 51 - Sayı: 1, 42–48. https://ajindex.com/articles/508925

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (3)

  1. Jia SW, Liu XY, Wang SC, Wang YF. Vasopressin Hypersecretion-Associated Brain Edema Formation in Ischemic Stroke: Underlying Mechanisms. J Stroke and Cerebrovasc Dis 2016; 25: 1289-300. [CrossRef] 2. Walcott BP, Kahle KT, Simard JM. Novel treatment targets for cerebral edema. Neurotherapeutics 2012; 9: 65-72. [CrossRef] 3. Bhardwaj A. Osmotherapy in neurocritical care. Curr Neurol Neurosci Rep 2007; 7: 513-21. [CrossRef] 4. Knapp JM. Hyperosmolar therapy in the treatment of severe head injury in children: mannitol and hypertonic saline. AACN Clin Issues 2005; 16: 199-211. [CrossRef] 5. Wykes V, Vindlacheruvu R. Intracranial pressure, cerebral blood flow and brain oedema. Surgery (Oxford) 2015; 33: 355-62. [CrossRef] 6. Palmer BF. Vasopressin receptor antagonists. Curr Hypertens Rep 2015; 17: 510. [CrossRef] 7. Barreca T, Gandolfo C, Corsini G, et al. Evaluation of the secretory pattern of plasma arginine vasopressin in stroke patients. Cerebrovasc Dis 2001; 11: 113-8. [CrossRef] 8. Zhao XY, Wu CF, Yang J, et al. Effect of arginine vasopressin on the cortex edema in the ischemic stroke of Mongolian gerbils. Neuropeptides 2015; 51: 55-62. [CrossRef] 9. Peri A. Clinical review: the use of vaptans in clinical endocrinology. J Clin Endocrinol Metab 2013; 98: 1321-32. [CrossRef] 10. Palmer BF, Rock AD, Woodward EJ. Dose comparison of conivaptan (Vaprisol®) in patients with euvolemic or hypervolemic hyponatremia-efficacy, safety, and pharmacokinetics. Drug Des Devel Ther 2016; 10: 339-51
  2. Wada K, Tahara A, Arai Y, et al. Effect of the vasopressin receptor antagonist conivaptan in rats with heart failure following myocardial infarction. Eur J Pharmacol 2002; 450: 169-77. [CrossRef] 12. Smith ML, Bendek G, Dahlgren N, Rosen I, Wieloch T, et al. Models for studying long-term recovery following forebrain ischemia in the rat
  3. A 2-vessel occlusion model. Acta Neurol Scand 1984; 69: 385-401. [CrossRef] 13. Taya K, Gulsen S, Okuno K, Prieto R, Marmarou CR, Marmarou A. Modulation of AQP4 expression by the selective V1a receptor antagonist, SR49059, decreases trauma-induced brain edema. Acta Neurochir Suppl 2008; 102: 425-9. [CrossRef] 14. Suzuki K, Ota H, Sasagawa S, Sakatani T, Fujikura T. Assay method for myeloperoxidase in human polymorphonuclear leukocytes. Anal Biochem 1983; 132: 345-52. [CrossRef] 15. Gage GJ, Kipke DR, Shain W. Whole animal perfusion fixation for rodents. J Vis Exp 2012; 65: pii: 3564. [CrossRef] 16. Lin TN, He YY, Wu G, Khan M, Hsu CY. E